AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Nov 4, 2015
29828_dirs_2015-11-04_5999edc1-2345-4bdb-8527-d5a8dfdd17ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-11-02
Reporting Person: Washington Robin L (EVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-02 | Common Stock | S | 1900 | $109.1284 | Disposed | 92396 | Indirect |
| 2015-11-02 | Common Stock | S | 4350 | $109.6105 | Disposed | 88046 | Indirect |
Footnotes
F1: The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: Sale prices reported for the transactions reported here range from $108.44 to $109.44. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F3: Sale prices reported for the transactions reported here range from $109.46 to $109.85. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.